BGI dna test service

Introduction

During the last decade, developments in the science of genetics and enormous advances in genetic technologies have altered our capability to understand diseases, make diagnoses and provide effective treatments. Transforming the world of prenatal testing, the advent of new DNA-based non-invasive prenatal testing (NIPT) has introduced a highly accurate screening strategy for fetal aneuploidy.

The NIFTY® test (Non-Invasive Fetal TrisomY test) was the first NIPT to enter clinical testing in 2010 and has been validated by a study on nearly 147,000 pregnancies. As of 31 December 2021, over 10,000,000 NIFTY tests have been carried out worldwide.

NIFTY® offers screening for some of the most common trisomies present at birth, inluding trisomy 21 (Down Syndrome), trisomy 18 (Edwards Syndrome) and trisomy 13 (Patau Syndrome). NIFTY® also provides testing options for sex chromosomal aneuploidies, chromosomal deletions/duplications and gender.

SUITABLE FOR:

pregnant women from week 8 of pregnancy(Mother and fetus are safe)
TA TIME:

7-12 working days
SAMPLE:

Sample of pregnant woman: 6-10ml Venous bloods Sample of Alleged father and child: Seminal Stain: Dry 10x 10cm2; Blood Stain: Dry 2x8cm2; Nails at least 5 pieces of difference nails with 2x2mm2; Buccal Swab at least 2 specimen; 4 - 6ml Venous Blood; Hair with follicle At least 5 pieces
TECHNOLOGY:

First Generation STR Technology